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A B S T R A C T
Population aging, as well as the handling of age-associated diseases, is a worldwide increasing concern. Among
them, Alzheimer's disease stands out as the major cause of dementia culminating in full dependence on other
people for basic functions. However, despite numerous efforts, in the last decades, there was no new approved
therapeutic drug for the treatment of the disease. Calcium-activated potassium channels have emerged as a
potential tool for neuronal protection by modulating intracellular calcium signaling. Their subcellular locali-
zation is determinant of their functional effects. When located on the plasma membrane of neuronal cells, they
can modulate synaptic function, while their activation at the inner mitochondrial membrane has a neuropro-
tective potential via the attenuation of mitochondrial reactive oxygen species in conditions of oxidative stress.
Here we review the dual role of these channels in the aging phenotype and Alzheimer's disease pathology and
discuss their potential use as a therapeutic tool.
1. Introduction
Life expectancy has increased by 10 years in the last 60 years
(Eatock 2019) and population aging, as well as the handling of age-
associated diseases, is a worldwide increasing concern. According to the
World Health Organization, the world's population over 60 will nearly
double by 2050, which translates into more than 2 billion people
(Chatterji 2013) and directly affects the course of health and economic
policies. Among age-related pathologies, currently, more than 1 billion
people are affected by neurodegenerative diseases, and almost 7 million
deaths annually result from these conditions (Group, GBD, 2015,
Erkkinen et al., 2018). Among them, Alzheimer's disease (AD) is con-
sidered to be the current major cause of dementia and ultimately leads
to full dependence on relatives or nursing care for basic functions
(Erkkinen et al., 2018).
Different therapeutic strategies have been explored over the years in
an attempt to alleviate the symptoms or slow down the progression of
the disease (Godyń et al. 2016). United States Food and Drug Admin-
istration (FDA) and the European Medicines Agency (EMA) approved
drugs for AD are the N-methyl-d-aspartate receptor (NMDA) antagonist
memantine, which acts mainly by reducing glutamate excitatory ac-
tivity; and acetylcholinesterase inhibitors, tacrine, donepezil,
galantamine, and rivastigmine, which increase the active-life of the
neurotransmitter acetylcholine (Colović et al. 2013, Matsunaga et al.,
2015). Nonetheless, since memantine approval in the early 2000s, there
was no new approved therapeutic drug for AD despite numerous efforts,
highlighting the importance of exploring new targets for preventing
neurodegeneration. Importantly, these drugs are not curing AD patients
(Fig. 1).
In the past decade, calcium-activated potassium channels (KCa) have
emerged as a potential tool for neuronal protection (Malinska et al.,
2010, Su et al. 2017, Sugunan et al. 2016, Piwońska et al. 2016, Dolga
et al. 2011, Dolga and Culmsee 2012, Dolga et al. 2012, Herrik et al.
2012). Among the different K+ selective channels and transporters,
calcium-activated potassium channels stand out for directly linking K+
dynamics to Ca2+ signaling.
In this review, we discuss the alterations in KCa channel activity and
the influence of its subcellular localization during aging and neurode-
generative disease onset. Subsequently, we address the prospective
therapeutic use of their modulators exploring potential benefits and
pitfalls.
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2. KCa channels and Ca2+ homeostasis
The KCa family of proteins can be further divided into large (KCa1.1/
BKCa/BK), intermediate (KCa3.1/SK4/IKCa/IK), and small (KCa2.1–2.3/
SKCa/SK) conductance channels. KCa channels are usually found in
complexes with voltage-gated Ca2+ channels (Grunnet and Kaufmann
2004). Changes in intracellular Ca2+ concentration increase the open
probability of KCa channels (Fakler and Adelman 2008), and in turn,
membrane hyperpolarization resulting from K+ efflux can deactivate
voltage-gated Ca2+ channels, limiting Ca2+ entry (Brenner et al. 2000).
2.1. BK/KCa1.1channels
Large conductance calcium-activated potassium (BK) channels dis-
play a conductance of 100-300 pS. BKCa channels are composed of two
distinct subunits, α and β, and are arranged as tetramers of α-subunits,
each associated, or not, to a β-subunit at its N-terminal portion (1:1).
The α-subunits have seven transmembrane domains (S0-S6), a pore-
forming loop (P-loop) between S5 and S6, and hydrophobic portions
(S7-S10) at the C-terminus (Butler et al. 1993). The four α-subunits
combine to form the K+ selective pore and acid aminoacid residues in
S2 and S3, as well as basic residues in S4, permit conformational
changes depending on the charge of those residues that translates into
voltage sensitivity to the channel. They are activated by voltage and
Ca2+ modulates their open probability. The α-subunit C-terminal por-
tion contains several regulatory sites, including the “Ca2+ bowl” motif
at S10, which are the main responsible for Ca2+ sensibility. The β-
subunits activity increases the channels Ca2+ sensibility (Wei et al.
1994, Ghatta et al. 2006, Brenner et al. 2000).
BKCa channels display a lower affinity for Ca2+ when compared to
the other subgroups of the family, having a half-maximal effective
concentration (EC50) of approximately 10 μM at 30 mV compared to
EC50 of 0.3 and 0.5 μM of IKCa and SKCa channels, respectively (Zhang
et al. 2018). Therefore, their activation takes place either when these
channels are coupled to Ca2+ influx sources, such as NMDA receptor-
mediated Ca2+ channels and L-type CaV, or when global intracellular
Fig. 1. Involvement of KCa channels in neurodegenerative conditions.
Presented in the figure are several mechanisms where KCa channels in organelles or on the plasma membrane (PM) play a role in neurodegeneration and neu-
roinflammation, including some effects that Amyloid-beta (Aβ) has on their open probability. Aβ oligomer treatment in aged neurons led to decreased mitochondrial
calcium (Ca2+) concentration (A). Aβ has differential effects on KCa opening on the PM. While the Aβ increases the open probability of IKCa and SKCa channels,
leading respectively to cas3 dependent cell death or memory deficits, the open probability of BKCa channel is decreased, resulting in enhanced cytosolic Ca2+ and
ER stress (B). Also on the PM, pro-inflammatory stimuli, being a risk factor for neurodegenerative diseases, affect KCa channels (C). Here, increased BKCa channel
currents and consequently, K+ efflux activates the NLRP1 inflammasome pathway leading to neuroinflammation, increased expression of lactate dehydrogenase
(LDH) and IL-1β, and neuronal apoptotic rates. On the other hand, SKCa channel activation in conditions of LPS-induced inflammation in microglia lead to attenuated
neuroinflammation via decreasing intracellular Ca2+ levels and reducing downstream events including TNF-α and IL-6 cytokine production and nitric oxide (NO)
release (C). At the IMM activation of both SKCa and BKCa channels induces mitohormetic effects that restore the oxidative balance and lead to cell survival. The
effects that Aβ deposition has on the KCa channels in the mitochondria include decreased BKCa channel activity and enhanced Ca2+ levels in the mitochondria (D).
BKCa channels at the perviascular endfeet of astrocytes modulate vasodilatation and contraction in response to neuronal activation; their inhibition attenuates
vasodilatation and contributes to brain hypoperfusion (E). Figure designed using Servier Medical Art.
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Ca2+ concentration is above the physiological concentration, which is
about 0.1 μM in rest and 1 μM in an excitatory state (Zhang et al. 2018,
Berkefeld and Fakler 2008). The kinetic of this activation is strongly
influenced by the β subunit isoform (Sarga et al. 2013).
BKCa channels are extensively expressed in the central nervous
system (CNS), being found in neurons, microglia, astrocytes and also in
myocites (Tseng-Crank et al. 1994, Contet et al. 2016, Longden et al.
2011). Presynaptically located BKCa channels’ activity in CA3 pyr-
amidal neurons leads to an inhibition of neurotransmitter release by
hyperpolarizing the plasma membrane in response to depolarization
and increased synaptic failure rate, preventing overexcitation. These
channels’ function is highly dependent on its intracellular localization,
when located in dendrites their activity leads to repolarization of
dendritic calcium spikes, regulating their duration and magnitude
(Bock and Stuart 2016). In addition, the activity of mitochondrial lo-
cated channels enhances cell viability by reducing ROS production and
mitochondrial Ca2+ content (Balderas et al. 2015).
2.2. IK/KCa3.1 channels
Intermediate conductance calcium-activated potassium (IKCa)
channels display a conductance of 25-100 pS and have a EC50 for Ca2+
of 0.3 μM (Zhang et al. 2018). Both IKCa and SKCa channels are struc-
turally very similar to BKCa channels. Their α-subunit S4 transmem-
brane domain presents a lower number of acidic residues compared to
BKCa channels, rendering it insensitive to voltage. IKCa and SKCa chan-
nels possess six transmembrane domains (S1–S6) and a conducting pore
located between S5 and S6 (Köhler et al. 1996, Joiner et al. 1997,
Logsdon et al. 1997, Ishii et al. 1997). IKCa and SKCa channels also lack
the S0 transmembrane domain, and their higher Ca2+ sensitivity is
mediated by the constitutive association of the Ca2+-binding protein
calmodulin (CAM) to the α-subunit C-terminal portion through the
calmodulin-binding domain. In both IKCa and SKCa channels, binding of
Ca2+ to CAM results in conformational changes that are responsible for
channel gating and subsequent channel opening and K+ efflux. In ad-
dition, these conformational changes enable the channels to open
during membrane hyperpolarization in excitable cells, which is less
likely for BKCa channels (Catacuzzeno et al., 2012, Maylie et al. 2004,
Lee and MacKinnon 2018, Coetzee et al. 1999). The IKCa channel is
normally activated by global Ca2+ signals resulting from Ca2+ released
from intracellular stores, or by influx through store operated Ca2+
channels (SOCs) present in the endoplasmic reticulum (ER). Moreover,
in excitable cells, IKCa channel activation-induced cell hyperpolariza-
tion actually increases the driving force for Ca2+ entry through SOCs.
This massive Ca2+ influx namely activates Ca2+-dependent ion chan-
nels, and efflux of K+ ions following Ca2+ influx hyperpolarizes the
membrane and increases the driving force for Ca2+ (Millership et al.
2011, Mark Duffy et al. 2004, Shepherd et al. 2007).
IKCa channels are expressed by enteric, sensory and sympathetic
neurons, being associated with a slow afterhyperpolarization, between
5 and 30 s, against the average of 100-500 ms (Neylon et al. 2004, Sah
1996). Contrasting with the intracellular localization of BKCa channels,
IKCa channel expression is not found in presynaptic regions. Instead,
within the CNS, IKCa channels are expressed in the somatic region of
cortical excitatory neurons, and somatic regions and dendritic segments
of inhibitory neurons in the hippocampus and cerebellar Purkinje
neurons (Turner et al. 2015). Nonetheless, these channels are mainly
found in brain tumors, astrocytes, microglia (Blomster et al. 2016), and
endothelial cells. As it is observed with BKCa channels, IKCa channels are
expressed in astrocytes endfeet, playing an essential role in neurovas-
cular coupling (Longden et al. 2011).
2.2.1. SK channels (KCa2.1/KCa2.2/KCa2.3)
Small conductance calcium-activated potassium (SKCa) channels
display a conductance of 2-25 pS with an EC50 for Ca2+ of 0.5 μM. They
are in structure very similar to IKCa channels. SKCa channels are mainly
expressed in the central and peripheral nervous system. Its three
members, KCa2.1/SK1, KCa2.2/SK2, and KCa2.3/SK3 are differentially
expressed in the human brain (Willis et al. 2017). When located in
somatic regions, SKCa channels facilitate NMDA receptor (NMDAR)
Mg2+ blockade, limiting Ca2+ influx and determining after-
hyperpolarization and intrinsic excitability (Pedarzani and Stocker
2008, Bloodgood and Sabatini 2007, Chen et al., 2014, Allen et al.
2011), and therefore suggesting that targeting SKCa channels might
have therapeutic value by modulating their effects on Ca2+ signaling
and NMDAR. On the other hand, when located in pyramidal neurons
dendritic spines, SKCa channels influence the amplitude of excitatory
postsynaptic potentials by limiting local Ca2+ influx and increasing the
threshold for long term potentiation (LTP) and synaptic plasticity
(Jones and Stuart 2013). Thus, as observed with the other KCa channels,
their subcellular localization is deeply related to their function and
might affect their potentiality as therapeutic targets (Kuiper et al. 2012,
Krabbendam et al. 2018). KCa channels are also found to be expressed in
mitochondrial and ER membranes and to play a role in ER-Ca2+ intake
(Kuum et al. 2012, Krabbendam et al. 2018). In addition, KCa channels
expressed in the inner mitochondrial membrane, which are responsible
for the transport of K+ from the highly concentrated cytosol to the
mitochondrial matrix, lead to depolarization of the mitochondrial
membrane and reduced Ca2+ intake, affecting ATP production, viabi-
lity, metabolism and ROS generation (Laskowski et al. 2016).
In summary, it is important to keep in mind that KCa channels’
different voltage and Ca2+ sensitivity properties lead to different in-
tracellular [Ca2+] signaling resulting in different cellular phenotypes.
3. The aging CNS in health and disease
The aging process is characterized by a cascade of cellular altera-
tions that culminates in the organism's functional decline. Its hallmarks
have been extensively studied in the last decades and include features
such as genomic instability, telomere shortening, altered epigenetic
patterns, proteostasis loss, deregulated nutrient-sensing, cellular se-
nescence, stem cell exhaustion, and altered intercellular communica-
tion (López-Otín et al. 2013). The tissue microenvironment equally
undergoes deep changes, and aging has been associated with altered
secretome, modifications in the extracellular matrix composition, and
increased background inflammation (Ueno et al. 2018, Lin et al. 2018).
In fact, inflammaging, the chronic low-grade inflammation character-
istic of aging, and immunosenescence, which leads to an impaired
immune response to new antigens, play a major role in the development
of age-related diseases. As observed in other tissues, in the central
nervous system (CNS), the aging process correlates to a significant in-
crease in basal levels of pro-inflammatory factors such as TNF-α (Tumor
necrosis factor α) and the cytokines IL-6 (Interleukin-6) and IL-8 (In-
terleukin-8) (Bodles and Barger 2004, Ye and Johnson 1999, 2001, Hu
et al. 2019). Moreover, an increase in senescent microglia is observed,
leading to a slower, although more lasting, response to stimuli, - what
can be explained by senescent-induced morphologic dystrophy; which
includes features such as hypertrophic cytoplasm, fragmented pro-
cesses, impaired phagocytosis, and reduced process motility and mi-
gration (Damani et al. 2011, Streit et al. 2004). This pro-inflammatory
environment is accompanied by increased oxidative stress and is partly
due to the senescence-associated secretory phenotype of activated as-
trocytes and microglia (Chinta et al. 2015).
Mitochondria, organelles responsible for oxidative phosphorylation,
go through significant alterations with aging (López-Otín et al. 2013),
displaying altered fission and fusion dynamics; decreased glucose me-
tabolism and membrane depolarization; impairment in oxidative
phosphorylation, Ca2+ signaling, and anti-oxidative mechanisms; as
well as increased reactive oxygen species (ROS) production (Bereiter-
Hahn 2014). The CNS is particularly affected since its main source of
ATP is through oxidative phosphorylation, consuming around 20% of
the organism’s total inhaled O2 in a rest state (Kann and Kovács 2007).
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Aged neurons display higher Ca2+ cytosolic levels partially due to an
enhanced Ca2+ influx through voltage-dependent Ca2+ channels. An
increased Ca2+ transfer from the ER to mitochondria through mi-
tochondria-ER membrane contact points is also observed (Calvo-
Rodríguez et al. 2016, Gant et al. 2015).
Intracellular Ca2+ concentration ([Ca2+]i) also affects synaptic ac-
tivity and is determinant for depolarization and, therefore, for neuronal
activity (Castelli et al. 2019). Imbalanced neuronal excitability is ob-
served with aging in hippocampal neurons, which affects memory.
[Ca2+]i is decreased in CA1 pyramidal neurons, due to an augmented
post burst afterhyperpolarization (Murphy et al. 2004, Oh et al., 2010),
and increased in CA3 pyramidal neurons (Oh et al., 2016). It is well
known that aging is the major risk factor for neurodegenerative dis-
eases, with the above-mentioned aging hallmarks being associated with
higher susceptibility to the development of these conditions (Hou et al.
2019). Among them, AD is the most prevalent, with its clinical onset
accompanied by reactive microgliosis, dystrophic neurites, and loss of
neurons and synapses (Mayeux and Stern 2012).
AD pathophysiology is characterized by the presence of hyperpho-
sphorylated Tau and Amyloid β (Aβ) aggregates. Tau is a microtubule
associated-protein mainly present in the axons of CNS neurons, there-
fore its hyperphosphorylated aggregates, neurofibrillary tangles (NFTs),
impair axonal transport and neuron intercommunication (Congdon and
Sigurdsson 2018). Aβ aggregates are found in the form of soluble oli-
gomers and fibrils (Aβ-derived diffusible ligands) – which interact with
different cell surface receptors and impair synaptic signaling. Aβ ag-
gregates also form insoluble amyloid plaques, whose presence in the
brain parenchyma and capillary vessel vicinities leads to an overall
higher inflammatory status (Murphy and LeVine 2010, Qi and Ma
2017). Moreover, Aβ oligomers treatment is known to lead to long term
potentiation inhibition and therefore decreased excitability (Yun et al.
2006, Pchitskaya et al., 2018).
It is interesting to note that γ-secretase enzymatic complex com-
ponents, such as presenilin-1 (PSEN1) and presenilin-2 (PSEN2), which
process amyloid precursor protein (APP) into Aβ, are enriched in mi-
tochondria-ER membrane contact points (Moltedo et al., 2019, Area-
Gomez et al. 2009). Mutations in PSEN1, prevalent in familial cases of
AD, result in a dysregulation of Ca2+ dynamics, with an increase in
cytosolic Ca2+ associated with a decrease in mitochondrial Ca2+
(Korkotian et al., 2019). In addition, ER Ca2+ is found to be elevated in
both aging and AD neurons (Bezprozvanny and Mattson 2008). Inter-
estingly, the treatment of both young and aged neurons with Aβ oli-
gomers lead to an increase in mitochondria-ER membrane contact
points. While in young neurons this increase translated into an aug-
mented transfer of Ca2+ from the ER to the mitochondria, in aged
neurons this transfer was found to be significantly diminished, resulting
in a decreased mitochondrial potential, increased ROS and apoptosis
(Calvo-Rodriguez et al. 2019) (Fig. 1A). Thus, unbalanced Ca2+
homeostasis contributes to neurodegenerations and synaptic loss ob-
served in aging and neurodegenerative conditions, impairing long-term
potentiation and favoring long-term depression (topic extensively re-
vised in (Bezprozvanny and Mattson 2008; Pchitskaya et al., 2018;
Egorova et al., 2015)).
4. The role of KCa channels in CNS aging and AD pathophysiology
4.1. BK/KCa1.1channels
BKCa channels voltage-sensitiveness and lower affinity for Ca2+
associated to its subcellular localization, determine their action either
in the repolarization or the afterhyperpolarization phase of the neu-
ronal action potential and can be either excitatory or inhibitory for
neuronal firing activity. Thus, this dual role in the CNS deeply interferes
with their therapeutic potential.
4.1.1. Alzheimer’s Disease
Several studies on genome-wide association showed a potential re-
lation between AD pathology (age-at-onset or disease duration) and a
SNP in the gene encoding BKCa α (KCNMA1, rs16934131). In addition,
hippocampal sclerosis, a comorbid neuropathological feature of AD was
also shown to be associated with a SNP in the gene encoding BKCa β2
(KCNMB2, rs9637454) (Beecham et al. 2009, Beecham et al. 2014,
Burns et al. 2011). BKCa channel activity is deeply impaired by Aβ
aggregates. Studies in rodent neurons showed that Aβ reduced BKCa
current both at the plasma membrane and also in the mitochondrial
fraction (Jafari et al. 2015). Neocortical pyramidal neurons in-
tracellularly injected with Aβ(1-42) display a decreased BKCa channel
activity, increasing Ca2+ influx and broader action potential spikes, a
phenotype that is also observed in the 3xTg AD mice (Yamamoto et al.
2011, Wang et al. 2015) (Fig. 1B). Moreover, the infusion of isopimaric
acid, a BKCa channel activator, into the ventricular-subarachnoid
system reversed the action potential spike width and led to a better
performance in the novel recognition test and Morris water maze
(Wang et al. 2015). In agreement with these data, BKCa channel α-
subunit knock-out mice displayed impaired spatial learning (Typlt et al.
2013). Moreover, Fmr1 knock out mice, a model for fragile X syndrome,
when treated with BKCa channel activator BMS-204352, displayed a
normalization of their dendritic spike pattern and glutamate home-
ostasis, in addition to their social recognition and interaction, non-so-
cial anxiety, and spatial memory (Hébert et al. 2014). BKCa and SKCa
channel dysfunction is also associated with the spiking irregularity
characteristic of spinocerebellar ataxia type 7 (SCA7). A low expression
of BKCa channels, PGC-1α acetylation, and impaired Sirt1 enzymatic
activity are contributors to SCA7 pathology. In fact, BKCa channel
overexpression into the deep cerebellar nucleus of SCA7 mice led to the
restoration of spike regularity, highlighting the importance of BKCa
channel neuronal expression for the mitochondrial function, neuronal
network and neuromuscular interactions (Stoyas et al. 2020).
However, Aβ aggregates action is not limited to cellular membrane
channels, intracerebroventricularly injected Aβ(1-42) induces a shift in
BKCa channels composition in the inner mitochondrial membrane
(IMM), with an increase in β4 subunit and a concomitant decrease in α
subunit expression. This variation in subunits composition leads to a
decrease in BKCa channel activity and consequently in mitochondrial
depolarizing potential (Jafari et al. 2015) (Fig. 1D).
Cerebrovascular abnormalities and hypoperfusion precede the
clinical onset of AD and correlate to its progression (Binnewijzend et al.
2016, Ruitenberg et al. 2005, Farkas and Luiten 2001). In this respect,
astrocytes have a major role in the regulation of cerebral blood flow,
functional hyperemia, and perivascular brain clearance (Attwell et al.
2010, Howarth 2014, Mawuenyega et al. 2010, Iliff et al. 2012,
Benveniste et al. 2019, Tarantini et al. 2017). Neurovascular coupling
dictates local vasodilatation and constriction in a process mediated by
BKCa channels present in astrocyte endfeet (Girouard et al. 2010,
Menyhárt et al. 2018). Through this mechanism, small increases in
[Ca2+]i induce dilatation, however substantial increases induces con-
striction (Girouard et al. 2010). Therefore, an increased of [Ca2+]i
observed in AD could favor vasoconstriction while BKCa channel in-
hibition leads to an attenuation of the vasodilatation in response to
neuronal activation (Girouard et al. 2010) (Fig. 1E). Moreover, of
special interest is the glymphatic system, a mechanism dependent on
AQ4 water channels present in astrocyte endfeet in which the cere-
brospinal fluid in the periarterial vicinities is transported to the inter-
stitial fluid (Benveniste et al. 2019, Iliff et al. 2012, Tarantini et al.
2017). AD cerebrovascular alterations affect the glymphatic system and
have a major role in Aβ clearance deficiency and therefore in its ac-
cumulation in the CNS (Mawuenyega et al. 2010, Iliff et al. 2012). In-
terestingly, brain samples from AD patients and transgenic mice models
for vascular Aβ deposition, displayed a substantial reduction in both
AQ4 and astrocyte BKCa channels expression (Wilcock et al., 2009).
Taken together, these reports indicate that BKCa channels dysfunction at
M. Trombetta-Lima, et al. International Journal of Biochemistry and Cell Biology 123 (2020) 105748
4
the perivascular astrocyte endfeet might impair function hyperemia,
compromising clearance, neuronal function and nutrient availability
contributing to AD progression and dementia.
4.1.2. Neuroinflammation
BKCa channels behavior upon different inflammatory stimuli and
models have been described. Neuroinflammation is a key feature in AD,
ergo the functionality of the resident immune cells of the CNS, the
microglia is deeply intertwined with the development of the disease
since its early stages (Hemonnot et al. 2019). Data on the microglial
BKCa current in juvenile and aged mouse brains showed no difference in
the BKCa current between various brain regions, or between ramified
and dystrophic microglial cells, suggesting that the activity of BKCa
might not be essential during aging (Schilling and Eder 2015). How-
ever, under pathological conditions, mimicked by lipopolysaccharide
(LPS) application led to the activation of BKCa channels through a toll-
like receptor 4 (TLR4)-mediated mechanism (Yang et al. 2019, Yeh
et al. 2019). Both pharmacological application of paxiline and siRNA-
mediated impairment of BKCa channel activity significantly inhibits
LPS-induced primary mouse microglial activation (Yang et al. 2019).
Moreover, chronic glucocorticoid exposure, which can be a result of
chronic stress and a risk factor for neurodegenerative diseases, modeled
by dexamethasone treatment, increased BKCa channel currents and
consequently K+ efflux. In turn, low intracellular [K+] activated the
NLRP1 inflammasome pathway leading to neuroinflammation, with
increased expression of lactate dehydrogenase (LDH) and IL-1β, and
neuronal apoptotic rates (Zhang et al. 2017). These effects were re-
verted by the BKCa channel inhibitor iberiotoxin, indicating that BKCa
channels play an essential role in regulating inflammatory signaling
(Zhang et al. 2017) (Fig. 1C).
4.1.3. Synaptic regulation
Aging is associated with a decrease in neuronal excitability and
longer afterhyperpolarization phases (Power et al. 2002). BKCa channel
subtypes were shown to be differentially expressed due to aging in rat
dorsal root ganglion neurons affecting their action potential after-hy-
perpolarization electrophysiological profile (Yu et al. 2015, Sesti 2016).
Nonetheless, these channels are prone to oxidation by ROS in specific
methionine and cysteine residues, which enhances their functionality
by increasing the period these channels stay in an open conformation in
pyramidal neurons of the hippocampus. This increased activity is re-
versed by treatment with reducing agents such as dithiothreitol (DTT)
(Gong et al. 2000). Also, in drosophila larval neuromuscular junction,
blockage of BKCa channel activity increased synaptic transmission tol-
erance to acute H2O2-induced oxidative stress (Bollinger et al., 2018).
Besides, an antioxidant supplemented diet with N-acetylcysteine, α-li-
poic acid and α-tocopherol lead to ameliorated memory impairment in
mice linked to changes in synaptosomal [K+] (Thakurta et al. 2014). In
agreement with this data, AD transgenic mice harboring human-APP
mutations exhibited depressed synaptic transmission associated with
increased presynaptic BKCa channel activity in the CA1 hippocampus
(Ye et al. 2010).
4.1.4. Mitochondrial function
BKCa channel activity in the mitochondria is equally important for
neuronal function. BKCa channel SLO-1 Drosophila melanogaster mutants
display mitochondria ultrastructural and functional defects, leading to
an increase in ROS generation which is associated with a reduced
lifespan. In addition, human BKCa channels overexpression in these
male mutants lead to an increased lifespan (Gururaja Rao et al. 2019).
However, BKCa channel SLO-1 knockdown and pharmacological in-
hibition with paxiline in Caenorhabditis elegans increased lifespan. In-
terestingly, this beneficial effect on the longevity of paxiline was de-
tectable only in old-treated worms, while the young-treated worms did
not benefit from the treatment. The function of the motor neurons was
improved in both paxiline-treated worms and SLO-1 mutants (Li et al.
2019). These studies indicate that BKCa channels play a role in longevity
and more studies are necessary to elucidate the potential alterations in
expression, splice variants and species-specific effects.
On the other hand, mitochondrial BKCa channels have been im-
plicated in the modulation of mitochondrial ROS production leading to
mitochondrial preconditioning or mitohormesis, a process where mild
stressors upregulate mitochondrial stress responses and confer protec-
tion (Raupach et al. 2019). Mice treated with the BKCa channel acti-
vator NS1619 and with the cell-permeant SOD mimetic MnTBAP
showed reduced NS1619-induced ischemic preconditioning in an
ischemia and reperfusion model. Interestingly, in a potential feedback
loop, activation of BKCa channels present in the IMM, through the
treatment with the agonists CGS 7184 and NS 1619, induced a reduc-
tion in ROS production in a complex I-dependent mechanism. This ef-
fect was reversed by co-treatment with BKCa channel inhibitors iber-
iotoxin and charybdotoxin (Kulawiak et al. 2008) (Fig. 1D). Moreover,
the NS1619-dependent anti-inflammatory and mucosal permeability-
sparing effects were ROS-dependent (Dai et al. 2017).
These results highlight BKCa channel dual role, at the same time that
its activity contributes to synaptic dysfunction, it is important for spike
pattern regulation and also has a neuroprotective function by reg-




IKCa channels were shown to be involved in Aβ oligomer-induced
reactive astrogliosis via its ability to increase the driving force for Ca2+
influx, proposing it as a target of interest for AD treatment.
Treatment with TRAM-34, a KCa3.1-specific inhibitor (Wulff et al.
2000), or the use of KCa3.1 knockout astrocytes leads to an attenuation
of TGF-β induced astrogliosis by processes involving reducing in-
tracellular calcium ([Ca2+]i) (Yu et al. 2014). Furthermore, blocking
KCa3.1 activity decreased Aβ oligomer-induced Ca2+ influx in astro-
cytes, suggesting that the KCa3.1 channel plays an important role in Aβ
oligomer-induced reactive astrogliosis. Moreover, KCa3.1 inhibition
through TRAM-34 treatment in the SAMP8 AD mouse model dimin-
ished microglia activation which was accompanied by preserved
memory performance. A similar protective phenotype was observed
when KCa3.1 knockout mice were administered with Aβ(1-42) in the
intrahippocampal region and compared to wild type control (Yi et al.
2016). Gene deletion or pharmacological blockade of KCa3.1 has been
shown to protect against store-operated Ca2+ entry (SOCE)-induced
Ca2+ overload and ER stress via the protein kinase B (AKT) signaling
pathway in astrocytes. Moreover, glial activation and neuroinflamma-
tion were attenuated in the hippocampi of APP/PSEN1 AD mice with
KCNN4 gene deletion, leading to reversed memory deficits and neu-
ronal loss as compared with APP/PSEN1 AD mice (Yu et al. 2018).
Although no role of IKCa channels concerning oxidative stress in AD has
been reported in the literature, they do play a role in aging vascular
endothelium, since several studies suggested that oxidative stress im-
paired IKCa function in old animals (Kong et al., 2015b, Choi et al. 2016,
Behringer et al. 2013).
4.2.2. Neuroinflammation
In microglial cells, the activity of KCa3.1 channels has been asso-
ciated with an activated microglial phenotype. Its inhibition through
TRAM-34 treatment was described to decrease nitric oxide synthase
expression and consequently nitric oxide and peroxynitrite production,
which in turn lead to neuroprotection by decreasing neurotoxicity
mediated by caspase 3 activation (Kaushal et al. 2007, Nguyen et al.
2017, Maezawa et al. 2011). Indeed, Aβ oligomer treatment increases
KCa3.1 channel activity and Aβ oligomer-induced microglial neuro-
toxicity was prevented by TRAM-34 treatment (Maezawa et al. 2011,
Jin et al. 2019) (Fig. 1B). In accordance with the mechanisms described,
M. Trombetta-Lima, et al. International Journal of Biochemistry and Cell Biology 123 (2020) 105748
5
KCa3.1 expression was increased in neurons and reactive astrocytes of
brain samples from AD patients (Jin et al. 2019, Yi et al. 2016).
Treatment of 5xFD AD mice with the KCa3.1 inhibitor Senicapoc re-
duced neuroinflammation and increased neuroplasticity (Jin et al.
2019). Also, in other organs involved in aging, KCa3.1 channels play an
essential role. For instance, a recent study showed protective effects of
KCa3.1 channels in cardiovascular function in aged mice by reversing
endothelial dysfunction without effects on the immune system (Mathew
John et al. 2019).
These studies highlight IKCa channels blockage as a potential
treatment for AD.
4.3. SK channels (KCa2.1/KCa2.2/KCa2.3)
4.3.1. Alzheimer’s Disease and aging
The delicate balance involving SK channels’ function in the CNS
reflects their critical function in AD. Cortical samples from AD patients
display higher expression of a shorter variant of SK2 (Murthy et al.
2008). Screening of alternative splice variants by microarray assays in
AD human brain and their bioinformatic analysis revealed significant
changes in splicing patterns of KCNN1 and KCNN2 genes, suggesting
that their function might be compromised during AD pathology
(Heinzen et al. 2007). In vivo studies in mice with lesioned hippo-
campus showed that treatment with apamin displayed an enhanced
performance in water maze tests (Ikonen and Riekkinen 1999, Messier
et al. 1991).
Interestingly, the fact that SKCa channels have been found to be
alternatively spliced in AD could possibly be linked to the dysregulation
in intracellular Ca2+ commonly associated with AD (Heinzen et al.
2007). Moreover, LTP leads to the internalization of these channels
mediated by PKA phosphorylation, promoting neuroplasticity (Lin et al.
2008). Agreeing with these results, SK3 expression in aged hippocampal
neurons contributes to reduced LTP and impaired trace fear con-
ditioning (Blank et al. 2003). On a mechanistic level, the importance to
hippocampal neurons is evidenced by the inhibition of SKCa channels
with apamin, which leads to augmented excitability of hippocampal
neurons, LTP, and synaptic plasticity, which translated into an en-
hanced cognitive performance (Stackman et al. 2002, Ngo-Anh et al.
2005). Similarly, in TgCRND8 AD mice, inhibition of SKCa channels
improved cholinergic function and nicotinic excitation, suggesting a
novel target for the treatment of attention defficits in AD (Proulx et al.
2015, Proulx et al. 2019). Additionally, KCa2.3/SK3 channel over-
expression induced LTP deficiency in hippocampal slices. In addition,
changes were found at the mRNA levels of genes involved in neuro-
degeneration such as the upregulation of dopamine receptors, GABA
receptor, and APP increase (Martin et al. 2017). However, SK3 deple-
tion in the cerebellum was sufficient to induce ataxia in transgenic mice
by disrupting afterhyperpolarization and thus increasing spontaneous
firing (Shakkottai et al. 2004).
Regarding SKCa channels in other cell types next to neurons in AD, it
has been found that even if they are present in platelets, they were
unresponsive to their inhibition (de Silva et al., 1998). SKCa channels
play also a role in aging-related endothelial dysfunction, which is in
part manifested as an impairment of NO-mediated relaxation, but in-
terestingly a reduced function of SKCa channels was also found (Kong
et al., 2015a). A recent study addressed the question of how endothelial
function is altered during aging and whether there is a difference be-
tween female and male cerebral arteries response to SKCa channel
modulation. It was demonstrated that the sensitivity of SKCa/IKCa
channel activation mildly decreases in females compared to males
during aging (Hakim et al. 2019). The authors have suggested that these
changes together with the altered function of GPCRs might contribute
to maintaining optimal cerebral blood flow in females versus males
during old age.
4.3.2. Neuroinflammation
An increasing number of studies report the implication of SKCa
channels on ROS production. In AD, one key characteristic is the acti-
vation of microglia, that contribute to the disease progression by re-
leasing reactive oxygen intermediates, a process primed by Aβ oligo-
mers (Van Muiswinkel et al., 1996). Interestingly, blocking SKCa
channels present in microglia and astrocytes was found to inhibit this
respiratory burst (Khanna et al. 2001). Moreover, activation of SKCa
channels significantly reduced LPS-stimulated microglia activation via
attenuation of intracellular Ca2+ levels and reduced downstream events
including TNF-α and IL-6 cytokine production and nitric oxide (NO)
release in activated microglia (Dolga et al. 2012) (Fig. 1C).
4.3.3. Mitochondrial function and Ca2+ signaling
As discussed in the previous section, it appears that blockers of SKCa
channels can alleviate memory deficits, while SKCa channel activators
worsen memory. However, in many cases, SKCa channel activation
promotes neuroprotection. Upon glutamate cytotoxicity in cerebral
ischemia and rotenone challenge in dopaminergic neurons, positive
modulation of the channel resulted in decreased intracellular Ca2+, and
modulation of NADPH oxidase, reduction of ROS production and con-
sequently leading to preservation of mitochondrial transmembrane
potential, mitochondrial dynamics and diminished apoptosis (Allen
et al. 2011, Dolga et al. 2014) (Fig. 1B). In addition, in cells lacking
NMDAR, it was found that SKCa channels still exert protective effects via
their localization on the IMM. The protection against glutamate-in-
duced oxytosis was mediated via mechanisms involving attenuation of
mitochondrial Ca2+ (Dolga et al. 2013, Honrath et al., 2017a,2017b)
(Fig. 1D). Thus, it is thought that SKCa channels located at the IMM are
equally important for the modulation of Ca2+ intracellular signaling
and neuronal viability. Interestingly, this protective phenotype is ob-
served even in conditions in which mitochondria-ER membrane contact
points are strengthened by genetically encoded bifunctional linkers,
where mitochondrial Ca2+ influx and vulnerability to oxidative stress
are increased (Honrath et al. 2018).
In addition to mitochondrial Ca2+ overload, alterations of ER Ca2+
homeostasis can lead to detrimental accumulation of the cytosolic Ca2+
that results in progressive neuronal cell death in neurodegenerative
disorders. Under conditions of prolonged (long-term) or severe (short-
term) ER stress, unfolded protein response (UPR) is initiated and this
was detected in post-mortem human AD brains (Matus et al., 2011).
Interestingly, the activity of ryanodine receptor (RyR) is increased in
3xTg-AD mice activity. As a consequence, the increase in RyR-mediated
Ca2+ release from the ER stores seems to be paralleled and compen-
sated by an increase in the activity of postsynaptic SKCa channels
(Chakroborty et al. 2015). Dysfunctional presynaptic and postsynaptic
calcium signaling conceal the underlying synaptic depression in pre-
symptomatic AD mice. Moreover, it was shown that SK2 channels are
present in ER membranes of neuronal HT22 cells, and their activation
by CyPPA protected against cell damage initiated by the ER stressors
(Richter et al. 2016). Sustained cytosolic Ca2+ levels and low ER Ca2+
load during ER stress could be largely restored by the activation of SK2
channels (Richter et al. 2016).
In our previous studies, we observed that SKCa channel activation
alone induced a mild increase in mitochondrial ROS levels (Richter
et al. 2015). Recently we found that this process is implicated in the
protection against oxidative toxicity in neurons, since scavenging mi-
tochondrial ROS diminished the SKCa-mediated protection
(Krabbendam et al. In Press). These data suggest a beneficial role for
mitohormesis providing an adaptive phenotype for later situations of
oxidative stress (Fig. 1D). The implication of SKCa channels in this
mechanism suggests that these channels might represent a potential
target for neurodegenerative diseases, since processes underlying the
pathophysiology of AD, Parkinson’s disease and aging include mi-
tochondrial oxidative stress (Carvalho et al. 2015, Onyango 2018).
Furthermore, due to the fact that neurons are extremely dependent on
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oxidative phosphorylation to obtain the high amount of energy required
for its normal functioning (Herrero-Mendez et al. 2009), mitochondrial
dysfunction can be detrimental. Interestingly, concomitantly with the
induction of slight mitochondrial ROS production following SKCa
channel activation, mitochondrial complex activity was decreased, and
an initial increase in glycolysis was observed in neuronal cells that
provided protection against oxidative stress (Krabbendam et al. In
Press). Notably, in the brain cortex of AD patients elevated levels of the
glycolytic enzymes pyruvate kinase and lactate dehydrogenase A
(LDHA) were found (Bigl et al. 1999). Furthermore, increased levels of
pyruvate dehydrogenase kinase, and concomitantly increased activity
of LDHA led to enhanced aerobic glycolysis which protected against Aß
toxicity in various neuronal lines (Newington et al., 2013, Newington
et al. 2011). Deficiencies in glycolysis are also age-related (Dong and
Brewer 2019). In longevity studies in C. elegans, we have observed that
activation of SKCa channels increases the median life-span. In addition,
SK channel activation increased the worm resistance to heat-induced
stress and improved survival (Krabbendam et al. In Press).
These results may reflect that the subcellular localization and al-
ternative splicing balance of these channels are worth investigating to
better understand their role during aging and the pathology of neuro-
degenerative diseases linked to both memory formation and cell sur-
vival.
5. Perspectives in intervention strategies
KCa channels modulate subcellular [Ca2+], resulting in the mod-
ulation of action potential propagation and cellular viability. KCa
function is deeply associated with its subcellular localization and can
lead to synaptic dysfunction. In this regard, the use of KCa activators has
been proposed as neuroprotective in cardiac/brain ischemia models,
while KCa blockers have been proposed for the treatment of different
neurodegenerative conditions, such as Parkinson's disease, multiple
sclerosis, and AD. However, both BKCa and SKCa channel activity was
also shown to be crucial for the cerebellar neuron spiking frequncies.
Therefore, inhibition of these channel activity is likely to cause ataxia.
BKCa channel activity was also shown to be important for functional
hyperemia. Thus, its pharmacological suppression might induce dys-
functional neurovascular coupling, favoring AD progression.
Nonetheless, in the last decade, KCa action role in neuroprotection has
been unveiled, especially associated with these channels’ localization in
the mitochondria, which enables them to tamper ROS production by
inhibiting mitochondrial Ca2+ overload and preservation of the re-
spiratory chain reaction. Thus, KCa channels expressed in the mi-
tochondria might be important for neuroprotection.
Several KCa channel modulators have been characterized (ex-
tensively reviewed in (Honrath et al., 2017a)), but their potential use
faces the challenge of altering the global activity of these proteins.
Further studies on the selective modulation of membrane versus mi-
tochondrial KCa might be valuable to translate their fine-tune modula-
tion of Ca2+ signaling to the clinic.
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